correo electrónico

CORREO ELECTRÓNICO

ventas@xianzhilou.com

Hogar / Noticias / El extracto de Reishi inhibe la infección por SARS-CoV-2 in vitro & vivo

Acerca de la compañía

Fundado en 2009, Tecnología de ganoherb (Fujiano) Corporación, Heredó la visión de nuestra empresa matriz-Fujian Xianzhilou Biological Science and Technology Co., Limitado., que pasó la cultura de la salud de los milenios y contribuyeron al bienestar de todos.

El extracto de Reishi inhibe la infección por SARS-CoV-2 in vitro & vivo

The novel coronavirus epidemic has ravaged mankind for three years so far. Since December 2022, normalized nucleic acid testing has been canceled in many places across China, and the negative nucleic acid test certificate for COVID-19 will no longer be checked. China has entered an era of co-existing with the epidemic. Facing the possible peak of infections, how to improve immunity and be the first person responsible for your own health has become a topic of greatest concern to the whole society.

As the advantages of traditional Chinese medicine in the prevention and control of the epidemic have become increasingly prominent, "Ganoderma lucidum", which has the effect of enhancing immunity and maintaining the balance of the overall function, has performed outstandingly in the prevention and control of the epidemic.

Entonces, doesGanoderma lucidum have any inhibitory effect on the novel coronavirus? ¿Pueden comer los pacientes con COVID-19?Ganoderma lucidum tener un efecto positivo en el cuerpo? Varios resultados de investigaciones recientes nos proporcionan evidencia favorable.

En abril 2020, la revista académica internacionalMoléculas publicó “Compuestos bioactivos naturales de hongos como candidatos potenciales para que los inhibidores de proteasa e inmunomoduladores se apliquen a los coronavirus”.

Este artículo revisa el descubrimiento y el progreso de la investigación de compuestos activos naturales de hongos en la inhibición del virus de la inmunodeficiencia humana. (VIH) proteasa. It proposes that active compounds of fungi, especially Ganoderma lucidum (triterpenoides, Polisacáridos y proteínas de pequeño peso molecular.) play an important role in inhibiting human immunodeficiency viral (VIH) proteasa.

Este estudio proporciona un posible fármaco candidato para la prevención y el tratamiento de los coronavirus., que se puede utilizar en el futuro para prevenir y tratar los coronavirus, especialmente para la prevención y el tratamiento de nuevas infecciones por coronavirus.

En 2021, “Actas de la Academia Nacional de Ciencias (PNAS) 2021 volumen. 118 No.5″ publicó un artículo “Identificación de inhibidores de la infección por el nuevo coronavirus a partir de medicamentos y medicamentos a base de hierbas enumerados”. El estudio encontró queGanoderma lucidum El extracto acuoso puede inhibir significativamente la infección del nuevo coronavirus. (SARS-CoV-2) tanto in vivo como in vitro.

Chinese herbal medicine water extract (1.0 g/20 mL, 5%) y Ganoderma lucidum polisacárido RF3 (0.25 mg/mL, 0.025%). IC50=half inhibitory (virus) dosis; CC50=half toxic dose

The results prove thatGanoderma lucidum polisacárido RF3 (2microgramos/ml) tiene un efecto antiviral significativo sobre el SARS-Cov-2 cultivado in vitro, y todavía tiene actividad inhibidora cuando se diluye a 1280 veces. But it has no toxicity to the virus host Vero E6 cells.

(A) Researchers observed the anti-sars-cov-2 effects of drugs and extracts in hamsters. On day 0, hamsters were infected by intranasal instillation of SARS-CoV-2. Después, the hamsters were orally administered the drug (30mg/kg/d) and the traditional Chinese medicine extract (200mg/kg/d), twice/d, and the viral load in the lungs of the hamsters was measured after 3 Días (n=5), *PAG < 0.05 ;* * PAG < 0.005(B) Body weight change after 3-d treatment, N=5 in the test group, N=6 in the control group. The results proved that compared with the infection control group, oral administration of Ganoderma lucidum polysaccharide RF3 can significantly reduce the viral load (contenido) en los pulmones de hámsters infectados con el virus SARS-Cov-2, and the animals did not lose weight during the test. In vivo and in vitro antiviral tests proved that Ganoderma lucidum polysaccharide RF3 significantly inhibited SARS-Cov-2 infection.

en febrero 2020, Professor Sun Guifan, vice chairman of the Precision Nutrition Professional Committee of the China Nutrition and Health Food Association, and the Institute of Preventive Medicine of China Medical University, publicly released the article “The second popular science series article on precise assistance in the prevention and treatment of novel coronavirus infections in terms of nutrition – the function of nutritional supplements”, announced to the public 12 kinds of nutritional supplements that can help prevent and treat novel coronavirus infections, Incluido Ganoderma lucidum, a traditional Chinese herbal medicine!

In the article, Professor Sun clearly pointed out thatGanoderma lucidum has an immune stimulating effect, que puede afectar directamente su capacidad para combatir las infecciones bacterianas y virales. Laboratory cell studies have shown that Reishi extract can stop or slow the growth of influenza virus, VIH, hepatitis B and many other viruses, reversing age-related decline in immune system function.

Professor Zhi-Bin Lin of Peking University Health Science Center, who has focused on the pharmacological research of Ganoderma lucidum por más de 50 años, introduced the antiviral effect and mechanism of Ganoderma lucidum in the article “Antiviral Effect of Ganoderma lucidum” published at the end of 2020, señalando que Ganoderma lucidum, especially the triterpenes contained in Ganoderma lucidum, have inhibitory effects on a variety of viruses.

Professor Zhi-Bin Lin preliminarily analyzed the mechanism of the antiviral effect of Ganoderma lucidum, which involves inhibiting the adsorption or penetration of viruses to cells, inhibiting virus uncoating, inhibiting the activity of enzymes (such as reverse transcriptase and protease) required for virus synthesis in cells, and hindering viral DNA or RNA replication but Ganoderma lucidum has no toxicity to host cells and has a synergistic effect in combination with known antiviral drugs.

The article also pointed out that the clinical efficacy of Ganoderma lucidum on viral diseases may be mainly related to the immune regulation effect of Ganoderma lucidumm, the anti-oxidation and free radical scavenging effect of Ganoderma lucidum, and the protective effect of Ganoderma lucidum on organs and tissues.

Modern research shows thatGanoderma lucidum is rich in dozens of active ingredients, which are the “messenger” for enhancing immunity.

En términos generales, the higher the content of active ingredients, the better the effect of enhancing immunity.

Tan pronto como 2017, GanoHerb and Fujian Provincial Center for Disease Control and Prevention jointly launched a research project on “The Effect of Ganoderma lucidum Granules on Immune Function”. The mice were divided into five groups, and they were given different doses of Ganoderma lucidum granules (by GanoHerb Technology (Fujiano) Corporación).

By comparing each dose group of the sample with the control group, it was found that: ①The high-dose sample group significantly enhanced the proliferation ability of mouse spleen lymphocytes induced by ConA and the delayed-type hypersensitivity of mice induced by DNFB; ②The medium and high-dose groups significantly enhanced the antibody generation ability, the high-dose group significantly increased the level of serum hemolysin in mice; ③The high-dose sample group significantly enhanced the activity of NK cells in mice.

The conclusion drawn from the test is that Ganoderma granules formulated with Ganoderma lucidum extract and Ganoderma sinense extract have the function of enhancing immunity. As a leading company focusing on the Ganoderma health industry, since the outbreak of the epidemic in 2020, GanoHerb has donated a total of 9.126 million yuan in cash and materials including Ganoderma lucidum esporas de aceite, Ganoderma lucidum spore powder and Ganoderma lucidum extract to help front-line medical staff and other staff members improve their own immunity and build a healthy defense line together. It is precisely because of this responsibility and commitment to strive to fight against the epidemic that in 2021, Tecnología de ganoherb (Fujiano) Corporation., a subsidiary of GanoHerb Group, was awarded the “Fujian Province Advanced Private Enterprise in Fighting against the Novel Coronary Pneumonia Epidemic”.

An era of competition for immunity has come. Have you stocked up on GanoHerb organic Ganoderma that strengthens immunity and regulates vitality?

w9

Obtén Touch

    Mensaje

    Cargando